Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population

The development of a non-invasive model to predict the presence of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease

(2016) George BB Goh et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Mopping up miRNA: An integrated HBV transcript disrupts liver homeostasis by sequestering miR-122

(2016) Joseph M. Luna et al.   JOURNAL OF HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease

(2016) Aitana Braza-Boïls et al.   LIVER INTERNATIONAL

Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation

(2016) Aditya Ambade et al.   Scientific Reports

Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients

(2016) Azeem Mehmood Butt et al.   Scientific Reports

Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7

(2015) Bin Zhu et al.   ARCHIVES OF VIROLOGY

Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma

(2015) Yajie Wang et al.   Cancer Biomarkers

Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States

(2015) Robert J. Wong et al.   GASTROENTEROLOGY

Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis

(2015) Philip P. Becker et al.   PLoS One

Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease

(2015) Jiexia Ding et al.   Scientific Reports

MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1

(2015) Gangli Yan et al.   MEDICAL SCIENCE MONITOR

MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury

(2015) Mitchell McGill et al.   Journal of Clinical Medicine

Retinoid X receptor α in human liver is regulated by miR-34a

(2014) Yuki Oda et al.   BIOCHEMICAL PHARMACOLOGY

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis

(2014) Carlos J Pirola et al.   GUT

The global burden of liver disease: The major impact of China

(2014) Fu-Sheng Wang et al.   HEPATOLOGY

Hepatitis B virus infection

(2014) Christian Trépo et al.   LANCET

Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

(2014) Yoshio Sumida   WORLD JOURNAL OF GASTROENTEROLOGY

Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease

(2013) Haveesh Sharma et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease

(2013) Kenneth Cusi et al.   JOURNAL OF HEPATOLOGY

MicroRNAs in liver disease

(2013) Gyongyi Szabo et al.   Nature Reviews Gastroenterology & Hepatology

MicroRNA-192 suppresses liver metastasis of colon cancer

(2013) L Geng et al.   ONCOGENE

Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease

(2012) Hae-Ki Min et al.   Cell Metabolism

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients

(2012) Pierre Bedossa et al.   HEPATOLOGY

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

(2012) Donghee Kim et al.   HEPATOLOGY

Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal

(2012) Mariana V. Machado et al.   JOURNAL OF HEPATOLOGY

miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease

(2012) Rui E. Castro et al.   JOURNAL OF HEPATOLOGY

Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor  -Klotho

(2012) T. Fu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Small RNAs have a large impact

(2012) Matthew Weiland et al.   RNA Biology

Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet

(2012) Volodymyr P. Tryndyak et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Expression Levels of MicroRNA-192 and -215 in Gastric Carcinoma

(2011) Yeunpo Chiang et al.   PATHOLOGY & ONCOLOGY RESEARCH

miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis

(2009) Can-Jie Guo et al.   JOURNAL OF HEPATOLOGY

Epidemiology of non-alcoholic fatty liver disease in China

(2008) Jian-Gao Fan et al.   JOURNAL OF HEPATOLOGY